Visteon Corporation (NYSE:VC) shares fell -0.30% in last trading session and ended the day at $67.26. VC Gross Margin is 12.30% and its has a return on assets of 41.50%. Visteon Corporation (NYSE:VC) quarterly performance is -42.02%.
Visteon Corporation (NYSE:VC) plans to release its fourth-quarter and full-year 2015 financial results prior to 7 a.m. ET on Thursday, Feb. 25. The company will host a conference call for the investment community at 9 a.m. ET to discuss the results and related matters. The conference call also is available to the general public via a live audio webcast.
Arcos Dorados Holding Inc (NYSE:ARCO) ended the last trading day at $2.44. Company weekly volatility is calculated as 5.62% and price to cash ratio as 5.68. Arcos Dorados Holding Inc (NYSE:ARCO) showed a weekly performance of 2.52%.
Arcos Dorados Holding Inc (NYSE:ARCO) is pleased to announce that 26 of its restaurant managers across 10 Latin American countries have won the Ray Kroc Award, an accolade that recognizes the top performing McDonald’s restaurant managers globally. The award recipients were among 340 McDonald’s restaurant managers around the world (representing the top one percent of restaurant managers) to receive the honor.
On 18 February, MediWound Ltd. (NASDAQ:MDWD) shares fell -3.09% and was closed at $6.89. MediWound Ltd. (NASDAQ:MDWD) year to date (YTD) performance is -19.32%.
On 2 February, MediWound Ltd. (NASDAQ:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces positive top-line results from the Company’s second Phase 2 clinical trial evaluating EscharEx® for debridement of dead or damaged tissue in chronic and other hard-to-heal wounds.
Derma Sciences Inc. (NASDAQ:DSCI) shares fell -7.08% in last trading session and ended the day at $3.15. DSCI Gross Margin is 38.20% and its has a return on assets of -30.10%. Derma Sciences Inc. (NASDAQ:DSCI) quarterly performance is -26.06%.
Derma Sciences Inc (NASDAQ:DSCI)‘s stock had its “outperform” rating reiterated by investment analysts at Oppenheimer in a research note issued on Friday, Marketbeat.com reports. They presently have a $7.00 price target on the stock, down from their previous price target of $8.00. Oppenheimer’s price target points to a potential upside of 102.31% from the stock’s current price.
Atlassian Corporation Plc (NASDAQ:TEAM) caters to the Technology space. It has a net profit margin of 4.40% and weekly performance is 9.67%. On the last day of trading company shares ended up at $22.00.
Atlassian Corporation Plc (NASDAQ:TEAM), announced that senior management will present at the 2016 JMP Securities Technology Conference in The Ritz-Carlton, San Francisco, CA on Tuesday, March 1, 2016.
Leave a Reply